You need to enable JavaScript to run this app.
Regulatory Recon: Merck Says June Cyber Attack Led to Lower Guidance Roche Leukemia Drug Picks Up Breakthrough Designation (28 July 2017)
Recon
Regulatory News
Michael Mezher